The US Department of Health and Human Services, under Secretary Robert F. Kennedy Jr., has recently made significant changes ...

Taysha Gene Therapies' positive results from the REVEAL study showcase TSHA-102's promise in treating Rett Syndrome. Click ...

Popular over-the-counter drugs used to treat uncomfortable urinary tract infections may come with a potential cancer risk.

California Cultured is hoping to launch its first products produced via plant cell culture in Q2 or Q3 of 2026.

Intellia Therapeutics shares fell 25% amid safety concerns in Phase 3 trials. Check out if today's selloff in NTLA stock is a ...

Stealth BioTherapeutics Inc. (the "Company" or "Stealth"), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving ...

Despite widespread support and an unassailable Democratic majority in both Colorado’s state House and Senate, House Bill 1312 ...

Daiichi Sankyo & Merck voluntarily withdraws patritumab deruxtecan BLA to treat locally advanced or metastatic EGFR-mutated NSCLC from US FDA: Basking Ridge, New Jersey Friday, Ma ...

The B-cell inhibitors market is experiencing robust growth, driven by the rising prevalence of the addressable patient population, which incl ...

Bristol Myers Squibb receives European approval for subcutaneous formulation of Opdivo across multiple solid tumour indications: Princeton, New Jersey Thursday, May 29, 2025, 15:0 ...